2020 Annual Meeting: March 5-7, 2020

Substance Use, Substance Use Disorders: Changing Concepts, Changing Patterns

The last two decades have seen enormous changes in public perceptions, laws and policies regarding substance use and substance use disorders. During this time, alcohol and drug use has increased markedly, especially opioids, marijuana and alcohol, leading to an opioid crisis and much debate about all of these substances. Research on substance use, its antecedents and consequences has seen substantial advances, from neurofunctioning to multi-level models of policy effects. At the same time, much remains to be learned. The 2020 APPA conference will present many of these areas, including many of the major studies are now underway that promise to provide important new information in the coming years. Major advances in behavioral and pharmacologic treatments have also been made, with more to be learned and done to better disseminate effective prevention efforts, and evidence-based treatments to those in need. The conference will also cover differences in important population subgroups (women, race/ethnic group), variation by life-cycle stage, stress, psychiatric comorbidity and suicide.

Speakers include NIDA and NIAAA directors, and internationally recognized leaders and experts in the areas to be presented. The conference will provide a lively interdisciplinary forum to discuss all of these issues, as well as considering important future directions.

Deborah S. Hasin, PhD

President 2020



Thursday, March 5  |  Friday, March 6  |  Saturday, March 6

Thursday, March 5, 2020

9:00 AM – 10:30 AM, Session 1: The View From National Institutes of Health

Deborah Hasin, PhD, Professor of Epidemiology; Columbia University

The View From NIAAA
George Koob, PhD, NIAAA Director

The View From NIDA
Nora Volkow, MD, NIDA Director

10:45 AM – 12:30 PM, Session 2: Policy

Silvia Martins, MD, PhD, Associate Professor of Epidemiology, Director, Center for Policy and Health Initiatives for Opioids and Other Substances (PHIOS), Columbia University 
Chair & Discussant

How can we Reverse the Tide of the Opioid Overdose Epidemic? Evidence on the Impact of Policy Solutions
Magdalena Cerdá, PhD, Associate Professor; Director, Center for Opioid Epidemiology and Policy, New York University

The Evolution of Marijuana Policy and how it has Shaped Marijuana Markets
Rosalie Pacula, PhD, Professor and Chair, School of Public Policy, University of Southern California

Recent Developments and Dynamics Between Opioid-Related Harms and Medical Cannabis Use in Canada
Benedikt Fischer, PhD, Professor, University of Toronto

Junior Scientist Poster Awardees: Brief Oral Presentations

1:30 PM – 3:00 PM, Session 3: Epidemiology

Charles Branas, PhD, Chair, Department of Epidemiology, Mailman School of Public Health, Columbia University
Chair & Discussant

Age, Period, and Cohort Effects in Substance Use and Mental Health in the 21st Century
Katherine Keyes, PhD, Associate Professor of Epidemiology, Co-Director, Psychiatric Epi Training Program, Columbia University

Breaking the Intergenerational Cycle of Adversity: Substance Abuse in the Boricua Youth Study
Christiane Duarte, PhD, Lambert Professor of Psychiatry; Director, Child Mental Health Disparities Group, Columbia University

Racial Inequity in Psychiatric and Substance Use Disorders Among African Americans
Debra Furr-Holden, PhD, Mott Endowed Professor; Director, Flint Center for Health Equity Solutions, Michigan State University

3:15 PM – 5:30 PM, Session 4: Neurofunctioning and Genetics

Diana Martinez, MD, Professor, Columbia University Department of Psychiatry
Chair & Discussant

Glutamate and the Neurobiology of Human Alcoholism
John Krystal, MD, Chair, Yale University Department of Psychiatry

Gender, Stress, & Substance Use Disorders
Rajita Sinha, PhD, Foundations Fund Professor; Director, Yale Interdisciplinary Stress Center, Yale University Department of Psychiatry

Genetics of Substance Disorders: Million Veteran Sample
Joel Gelernter, MD, Foundations Fund Professor; Director, Division of Human Genetics, Yale University Department of Psychiatry

Adolescent Brain & Cognitive Development (ABCD) Study
Sandra Brown, PhD, Distinguished Professor of Psychology and Psychiatry; Vice Chancellor for Research, University of California, San Diego

5:30 PM – 7:00 PM, Poster Session I (*Poster boards are 36 inches high and 48 inches wide)

Friday, March 6, 2020

8:00 AM – 9:00 AM, Junior Investigator Breakfast Roundtable

8:00 AM – 9:30 PM, Poster Session II (*Poster boards are 36 inches high and 48 inches wide)

9:30 AM – 12:50 PM, Session 5: Measurement: Diagnosis, Outcomes

Eric Strain, MD, Professor and Executive Vice Chair for Psychiatry, Johns Hopkins Bayview Medical Center
Chair & Discussant

Presentation of Zubin Award
Bridget Grant, PhD, Former Director, NIAAA Lab of Epidemiology

Substance Use Disorder Nomenclature: DSM-5, ICD-11
Wilson Compton, MD, Deputy Director, NIDA

Meaningful Clinical Trial Endpoints
Stephanie O’Malley, PhD, Professor of Psychiatry; Director, Substance Abuse Research Division, Yale University

Presentation of Hoch Award
Deborah Hasin, PhD

10:30 AM – 12:00 PM, Session 6: Exposure Consequences I

Edward Nunes, MD, Professor of Psychiatry, Yale University; NIDA National Advisory Council Member
Chair & Discussant

Cannabis and Psychosis
Robin Murray, MD, Professor of Psychiatry (and former Dean), Institute of Psychiatry, Kings College London

Substance Use, Overdose and Suicide
Amy Bohnert, PhD, Associate Professor; Co-director, Mental Health Innovation, Services and Outcomes Program, University of Michigan

Predicting Suicide Among Persons With Substance Use Disorders in the Population of Denmark
Jaimie Gradus PhD, Associate Professor, Epidemiology/Psychiatry, Boston University

12:00 PM – 1:00 PM, APPA Annual Business Conference

2:00 PM – 5:00 PM, Session 7: Exposure Consequences II

Alan Budney, PhD, Professor, Dartmouth College
Chair & Discussant

Linking Maternal Risk Traits to Specific Child Diagnoses in Fetal Alcohol Spectrum Disorders (FASD)
Philip May, PhD, Professor, Global Public Health, University of North Carolina

Alcohol Stimulating and Sedating Effects
Andrea King, PhD, Professor of Psychiatry, Director, Addiction Research Laboratory, University of Chicago

The Risks and Benefits of Naloxone Prescribing to Drug Users: A Randomized, Controlled Trial
Sandra Comer, PhD, Professor of Psychiatry; Director, Opioid Laboratory, Columbia University

Cannabis Use Disorder: Current Perspectives
Margaret Haney, PhD, Professor of Psychiatry, Director, Cannabis Research Laboratory, Columbia University

Hoch Award Presentation
Mark Olfson, MD, Professor of Psychiatry, Columbia University; Co-Director, AHRQ Center for Education & Research on Mental Health Therapeutics

Saturday, March 7, 2020

9:00 AM – 11:50 PM, Session 8: Evidence-Based Treatments and Their Dissemination

John Rotrosen, MD, Professor, Department of Psychiatry, New York University
Chair & Discussant

Robins-Guze Award

Pharmacotherapy and Pharmacogenetics of Alcohol Use Disorder
Henry Kranzler, MD, Professor of Psychiatry; Director, Center for Studies of Addiction, University of Pennsylvania

Pharmacological Treatment, Opioids
Joshua Lee, MD, Associate Professor; Director, ABAM Fellowship in Addiction Medicine, New York University

Behavioral Treatments for Substance Use Disorders
Katherine Carroll, PhD, Kent Professor of Psychiatry; Director, Psychosocial Research on Addictions, Yale University

Alcohol and Other Drug Use Screening and Intervention: Efficacy, Effectiveness, Both, or Neither? 
Richard Saitz, MD, Professor and Chair, Community Health Services, Boston University School of Public Health

Meeting Concludes

APPA 2019-2020 Council


Deborah S. Hasin, PhD (Columbia University)

President Elect

James Potash, MD (Johns Hopkins University)

Vice President

Kathleen Merikangas, PhD (National Institute of Mental Health)


William S. Stone, PhD (Harvard Medical School)


Joshua Breslau, ScD (RAND Corporation)

Membership Chair

Helen Wilson, PhD (Stanford University)


Jo-Ann L. Donatelli, PhD (Brown University)


Raymond DePaulo, MD (Johns Hopkins University School of Medicine) 

Stephen E. Gilman, ScD (Eunice Kennedy Shriver National Institute of Child Health and Human Development) 

Michael J. Lyons, PhD (Boston University) (Past President)

Susan L. Santangelo, ScD (Maine Medical Center)